ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,945Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 11

$758K Total Retail Price of All Prescriptions

Rank: 3 out of 11

637 Patients Receiving at Least One Drug in Part D
97%Patients 65 Years and Older
9% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 637 patients filled at least one prescription for a schedule two drug, compared to an average of 11%.

Schedule Three
Controlled Substances

18% of this provider’s 637 patients filled at least one prescription for a schedule three drug, compared to an average of 22%.

Risky Drugs to Seniors

2% of this provider’s 13,670 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
LEVOTHYROXINE SODIUM 654 652 1 2
LISINOPRIL 513 498 2 3
HYDROCODONE-ACETAMINOPHEN 474 446 S3 3 1
SIMVASTATIN 439 427 4 6
AMLODIPINE BESYLATE 423 413 5 7
FUROSEMIDE 306 299 6 4
METOPROLOL TARTRATE 296 296 7 8
OMEPRAZOLE 289 284 8 5
DONEPEZIL HCL 260 256 9 11
GABAPENTIN 259 254 10 9
SERTRALINE HCL 255 254 11 18
PRAVASTATIN SODIUM 238 234 12 24
ATORVASTATIN CALCIUM 226 221 13 16
POTASSIUM CHLORIDE 210 202 14 10
TRAMADOL HCL 207 206 15 22
DIOVAN 202 201 16 46
WARFARIN SODIUM 199 195 17 12
METFORMIN HCL 197 194 18 15
ATENOLOL 192 180 19 23
ALENDRONATE SODIUM 183 172 20 25
NAMENDA 177 166 21 13
CLOPIDOGREL 176 176 22 26
CITALOPRAM HBR 172 170 23 14
CARVEDILOL 167 167 24 19
METOPROLOL SUCCINATE 163 163 25 20
ZOLPIDEM TARTRATE 162 157 26 21
ALLOPURINOL 162 162 26 30
HYDROCHLOROTHIAZIDE 159 153 28 17
FLUOXETINE HCL 134 130 29 77
PLAVIX 133 133 30 33
AZITHROMYCIN 121 119 31 34
TRIAMTERENE-HCTZ 120 120 32 86
GLIMEPIRIDE 120 120 32 57
PANTOPRAZOLE SODIUM 106 106 34 47
COLESTIPOL HCL 103 103 35 94
SYNTHROID 102 102 36 97
KLOR-CON 10 101 101 37 98
TAMSULOSIN HCL 98 94 38 28
HYDRALAZINE HCL 88 88 39 69
CLONIDINE HCL 85 85 40 44
EVISTA 83 83 41 79
LOVASTATIN 82 82 42 74
GEMFIBROZIL 74 73 43 114
PREDNISONE 71 71 44 35
FLUTICASONE PROPIONATE 71 69 44 36
CYMBALTA 69 69 46 48
CRESTOR 69 69 46 84
FENOFIBRATE 68 66 48 85
KLOR-CON 8 67 61 49 119
LANTUS SOLOSTAR 67 66 49 61
OXYBUTYNIN CHLORIDE ER 66 66 51 120
MIRTAZAPINE 66 66 51 27
ENALAPRIL MALEATE 63 59 53 50
MEGESTROL ACETATE 62 60 R 54 53
CIPROFLOXACIN HCL 61 61 55 83
DIGOXIN 60 60 56 37
VESICARE 59 59 57 129
BENAZEPRIL HCL 58 58 58 63
PREMARIN 56 56 R 59 54
AMITRIPTYLINE HCL 54 54 R 60 139
JANUVIA 54 54 60 56
CELEBREX 52 52 62 31
EXELON 52 52 62 77
TRAZODONE HCL 51 45 64 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 18, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.